Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirin.

Frederick LG, Suleymanov OD, Szalony JA, Taite BB, Salyers AK, King LW, Feigen LP, Nicholson NS.

Circulation. 1998 Aug 25;98(8):813-20.

PMID:
9727553
2.

Assessment of platelet function assays.

Nicholson NS, Panzer-Knodle SG, Haas NF, Taite BB, Szalony JA, Page JD, Feigen LP, Lansky DM, Salyers AK.

Am Heart J. 1998 May;135(5 Pt 2 Su):S170-8. Review.

PMID:
9588396
3.

Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist.

Badimon JJ, Meyer B, Feigen LP, Baron DA, Chesebro JH, Fuster V, Badimon L.

Eur J Clin Invest. 1997 Jul;27(7):568-74.

PMID:
9263744
4.

The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb beta 3.

Loftus JC, Halloran CE, Ginsberg MH, Feigen LP, Zablocki JA, Smith JW.

J Biol Chem. 1996 Jan 26;271(4):2033-9.

6.
7.

Extended inhibition of platelet aggregation with the orally active platelet inhibitor SC-54684A.

Szalony JA, Haas NF, Salyers AK, Taite BB, Nicholson NS, Mehrotra DV, Feigen LP.

Circulation. 1995 Jan 15;91(2):411-6.

PMID:
7805245
8.

Characterization of Binding of an RGD Mimetic, [(3)H]-SC-52012, to Platelet GPIIb/IIIa.

Panzer-Knodle SG, Jacqmin P, Page JD, Nicholson NS, Zablocki JA, Engleman VW, Feigen LP.

Platelets. 1995;6(5):288-95. doi: 10.3109/09537109509023569.

PMID:
21043715
9.

Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats.

Wu X, Helfrich MH, Horton MA, Feigen LP, Lefkowith JB.

J Clin Invest. 1994 Sep;94(3):928-36.

10.

A new method for measurement of plasma concentration of orally active glycoprotein IIb/IIIa antagonists.

Salyers AK, Szalony JA, Taite BB, Haas NF, Mehrotra DV, Feigen LP, Nicholson NS.

Thromb Res. 1994 Aug 15;75(4):409-17.

PMID:
7997979
11.

SC-49992--a potent and specific inhibitor of platelet aggregation.

Nicholson NS, Panzer-Knodle SG, King LW, Taite BB, Keller BT, Tjoeng FS, Engleman VW, Giorgio TD, Feigen LP.

Thromb Res. 1994 Jun 1;74(5):523-35.

PMID:
8085253
13.

Species variation in the effect of glycoprotein IIb/IIIa antagonists on inhibition of platelet aggregation.

Panzer-Knodle S, Taite BB, Mehrotra DV, Nicholson NS, Feigen LP.

J Pharmacol Toxicol Methods. 1993 Sep;30(1):47-53.

PMID:
8241546
14.

Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery.

Rote WE, Werns SW, Davis JH, Feigen LP, Kilgore KS, Lucchesi BR.

Cardiovasc Res. 1993 Mar;27(3):500-7.

PMID:
8490951
15.

Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation.

Fok KF, Panzer-Knodle SG, Nicholson NS, Tjoeng FS, Feigen LP, Adams SP.

Int J Pept Protein Res. 1991 Aug;38(2):124-30.

PMID:
1783488
16.

External ocular inflammatory effects of lipoxygenase enzyme products.

Napoli SA, Helm C, Insler MS, Ensley HE, Pretus HA, Feigen LP.

Ann Ophthalmol. 1990 Jan;22(1):30-4.

PMID:
2155571
17.

Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors.

Haskel EJ, Adams SP, Feigen LP, Saffitz JE, Gorczynski RJ, Sobel BE, Abendschein DR.

Circulation. 1989 Dec;80(6):1775-82.

PMID:
2513145
18.

Inhibition of soybean lipoxygenase by SKF 525-A and metyrapone.

Pretus HA, Ignarro LJ, Ensley HE, Feigen LP.

Prostaglandins. 1985 Oct;30(4):591-8.

PMID:
3936118
19.

Metabolites of arachidonic acid.

Feigen LP.

Bibl Cardiol. 1984;(38):91-8. Review. No abstract available.

PMID:
6442576
20.
21.
22.

Differential effects of ibuprofen and indomethacin in the regional circulation of the dog.

Feigen LP, King LW, Ray J, Beckett W, Kadowitz PJ.

J Pharmacol Exp Ther. 1981 Dec;219(3):679-84.

PMID:
7299691
23.

Vascular influences of prostaglandins: introduction.

Feigen LP, Hyman AL.

Fed Proc. 1981 May 15;40(7):1985-6. No abstract available.

PMID:
7227555
24.

Actions of prostaglandins in peripheral vascular beds.

Feigen LP.

Fed Proc. 1981 May 15;40(7):1987-90.

PMID:
7014257
25.

Intramedial renal arterial nerves.

Knight DS, Bazer GT, Feigen LP, Kadowitz PJ.

Blood Vessels. 1981;18(4-5):187-95. No abstract available.

PMID:
7296012
26.

Peripheral vasodilator effects of prostaglandins: comparison of 6-keto-prostaglandin E1 with prostacyclin and escape from prostaglandin E2 in the mesenteric vascular bed.

Feigen LP, Chapnick BM, Hyman AL, King L, Marascalco B, Kadowitz PJ.

J Pharmacol Exp Ther. 1980 Sep;214(3):528-34. No abstract available.

PMID:
6995573
27.

Cardiopulmonary actions of prostaglandin 6-keto-E1 in the anesthetized dog.

Nandiwada P, Hyman AL, Feigen LP, Kadowitz PJ.

Arch Int Pharmacodyn Ther. 1980 May;245(1):118-28.

PMID:
7190813
28.

Cardiovascular actions of prostacyclin (PGI2) in the cat.

Lippton HL, Paustian PW, Mellion BT, Nelson PK, Feigen LP, Chapnick BM, Hyman AL, Kadowitz PJ.

Arch Int Pharmacodyn Ther. 1979 Sep;241(1):121-30.

PMID:
393193
29.

Evidence for separate PGD2 and PGF2 alpha receptors in the canine mesenteric vascular bed.

Feigen LP, Chapnick BM.

Prostaglandins. 1979 Aug;18(2):221-33.

PMID:
230544
30.

Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2.

Kadowitz PJ, Chapnick BM, Feigen LP, Hyman AL, Nelson PK, Spannhake EW.

J Appl Physiol Respir Environ Exerc Physiol. 1978 Sep;45(3):408-13.

PMID:
359514
31.

Differential effects of prostaglandins in the mesenteric vascular bed.

Chapnick BM, Feigen LP, Hyman AL, Kadowitz PJ.

Am J Physiol. 1978 Sep;235(3):H326-32. No abstract available.

PMID:
358842
32.

Prostaglandins: renal vascular responses to bradykinin, histamine, and nitroglycerine.

Feigen LP, Chapnick BM, Flemming JE, Kadowitz PJ.

Am J Physiol. 1978 Apr;234(4):H496-502.

PMID:
417634
33.

Comparative effects of arachidonic acid, bisenoic prostaglandins, and an endoperoxide analog on the canine pulmonary vascular bed.

Kadowitz PJ, Spannhake EW, Greenberg S, Feigen LP, Hyman A.

Can J Physiol Pharmacol. 1977 Dec;55(6):1369-77. No abstract available.

PMID:
597784
34.

Renal vascular effects of endoperoxide analogs, prostaglandins, and arachidonic acid.

Feigen LP, Chapnick BM, Flemming JE, Flemming JM, Kadowitz PJ.

Am J Physiol. 1977 Nov;233(5):H573-9.

PMID:
920820
35.

Effects of alpha-adrenergic blockade on renal function in hemorrhagic shock.

Feigen LP, Coleman B, Glaviano VV.

Am J Physiol. 1977 May;232(5):F409-15.

PMID:
871163
36.
37.

[The high frequency components of the heart sounds in normal subjects (author's transl)].

Luisada AA, Feigen LP, Bhat PK, Perez GL, Aravanis C.

G Ital Cardiol. 1977;7(1):33-40. Italian.

PMID:
852645
38.

Effects of 13, 14-dehydroprostacyclin methyl ester on the feline intestinal vascular bed.

Paustian PW, Chapnick BM, Feigen LP, Hyman AL, Kadowitz PJ.

Prostaglandins. 1977;14(6):1141-52.

PMID:
341229
39.

The effect of indomethacin on renal function in pentobarbital-anesthetized dogs.

Feigen LP, Klainer E, Chapnick BM, Kadowitz PJ.

J Pharmacol Exp Ther. 1976 Aug;198(2):457-63.

PMID:
948037
40.

Myocardial performance during hemorrhagic shock in the pancreatectomized dog.

Coleman B, Kallal JE, Feigen LP, Glaviano VV.

Am J Physiol. 1975 May;228(5):1462-8.

PMID:
1130549
41.

Changing views on the mechanism of the first and second heart sounds.

Luisada AA, MacCanon DM, Kumar S, Feigen LP.

Am Heart J. 1974 Oct;88(4):503-14. Review. No abstract available.

PMID:
4606328
42.

On the unitary nature of cardiac vibrations.

Luisada AA, Feigen LP, Mori K.

Jpn Heart J. 1973 Sep;14(5):406-13. No abstract available.

PMID:
4543463
43.

Technical progress in phonocardiography and pulse tracings.

Luisada AA, Feigen LP.

Acta Cardiol. 1973;28(4):392-414. No abstract available.

PMID:
4542749
44.

Design and first results of a new phonocardiograph.

Luisada AA, MacCanon DM, Feigen LP, Griffen PM, Darrel B.

Am J Cardiol. 1971 Aug;28(2):134-9. No abstract available.

PMID:
5560822
45.

Physical characteristics of sound and hearing.

Feigen LP.

Am J Cardiol. 1971 Aug;28(2):130-3. No abstract available.

PMID:
5560821
46.

New studies on the first heart sound.

Luisada AA, MacCanon DM, Coleman B, Feigen LP.

Am J Cardiol. 1971 Aug;28(2):140-9. No abstract available.

PMID:
4254391
47.

Frequency distribution of the heart sounds in normal man.

Sakai A, Feigen LP, Luisada AA.

Cardiovasc Res. 1971 Jul;5(3):358-63. No abstract available.

PMID:
5558733

Supplemental Content

Loading ...
Support Center